Introduction
Nasopharyngeal carcinoma (NPC) is a malignant tumor highly prevalent among Southern Chinese. NPC is strongly associated with Epstein-Barr virus (EBV), a human herpesvirus . NPC tumor cells regularly carry the EBV genome as a plasmid and express a limited number of EBV gene products such as EBV-determined nuclear antigen 1 (EBNA1), small nonpolyadenylated RNA known as EBER (EBV-encoded small RNA), the transcripts from the BamHI-A region (BARF0) and latent membrane proteins (LMP1, LMP2A and LMP2B). Among them, LMP1 was shown to have some pleiotropic biological activities against epithelial cells. However, LMP1 is not expressed in tumor cells in about two-thirds of NPC cases. Therefore, the precise contribution of EBV to the pathogenesis of NPC is still not clear.
Recently, we have found that EBV infection induces expression of insulin-like growth factor 1 (IGF-1) (Yu and Rohan, 2000; Fu¨rstenberger and Senn, 2002) in the gastric carcinoma (GC)-derived EBV-negative cell line NU-GC-3 (Iwakiri et al., 2003) . Transfection of individual EBV latent genes into NU-GC-3 cells revealed that EBER was responsible for IGF-1 expression. Addition of recombinant IGF-1 accelerated growth of NU-GC-3 cells, while growth of the EBVconverted NU-GC-3 cells was blocked by treatment with an anti-IGF-1 antibody, suggesting that IGF-1 induced by EBER acts as an autocrine growth factor for GC. Furthermore, EBV-positive GC biopsies consistently expressed IGF-1. These findings strongly suggest that EBV directly affects the pathogenesis of EBVassociated GC.
Since EBER is invariably expressed in NPC, these findings prompted us to study whether the same scenario is applicable to NPC. By using the NPCderived cell lines C666-1 (Cheung et al., 1999) , CNE1 (Zeng et al., 1982) and HONE1 (Yao et al., 1990) , we examined whether growth of NPC tumor cells was dependent on IGF-1.
Results

IGF-1 expression in EBV-infected NPC-derived cell lines
To assess the role of IGF-1 in the growth of NPC cells, both the NPC-derived EBV-negative cell line CNE1 and the EBV-positive cell line C666-1 were used. CNE1 cells were infected with recombinant EBV (rEBV), which contains the enhanced green fluorescent (EGFP) gene and the neomycin-resistance (Neo r ) gene (Maruo et al., 2001) , using a 'cell-to-cell' infection procedure as previously described (Imai et al., 1998) and EBVinfected cell clones were isolated. A total of 10 representative cell clones were analysed to ascertain whether cells were infected with EBV. All cell clones were 100% positive for EBNA by the immunofluorescence assay (Figure 1a) . Southern analysis of cell clones probed with the BamHI W fragment of EBV DNA also indicated that all clones were infected with EBV (data not shown). Immunoblot analysis demonstrated that the EBV-positive CNE1 cell clones were positive for EBNA1, but negative for other EBNAs and LMP1 (Figure 1b) . RT-PCR analysis revealed that EBVpositive cell clones used the Q promoter for EBNA transcription, and were positive for EBER and BARF0, but negative for LMP2B. Additionally, they expressed a small amount of LMP2A (Figure 1b ). Their patterns of EBV expression were identical to those of LMP1-negative NPC, that is, the so-called type I latency, which is found in about two-thirds of the cases of NPC. It was also shown that C666-1 cells retained the type I latency (Figure 1b) .
EBV-positive and -negative CNE1 cell clones and C666-1 cells were examined for the expression of various growth factors such as IGF-1, HGF, EGF and IL1-b, which are known to act as growth factors for epithelial cells. RT-PCR analysis revealed that expression of IGF-1 was highly induced in EBV-positive CNE1 and C666-1 cells (Figure 1c) . Similar results were also obtained when NPC-derived EBV-negative NPC line HONE1 was examined. EBV-converted HONE1 cells represented type I latency and expressed IGF-1 (Figure 1d ).
IGF-1 induction was further confirmed by an ELISA assay of culture supernatants. After 3 days of culture of 2 Â 10 5 cells in 1 ml of medium, EBV-positive CNE1, HONE1 and C666-1 cells secreted 20-30 ng of IGF-1. In contrast, the secreted IGF-1 levels of EBV-negative CNE1 and HONE1 cells were B5 ng (Figure 1e ).
Role of EBER in IGF-1 induction in NPC-derived cell lines
Next, it was examined which of the three EBV genes expressed in these cells (EBNA1, EBER and BARF0) was responsible for IGF-1 induction. CNE1 cells were Since EBER was shown to bind an interferon-induced protein kinase (PKR) and inhibit its activation (Nanbo et al., 2002) , we examined the effect of PKR inhibitor, 2-aminopurine (5 mM), and interferon-a on IGF-1 expression in CNE1 cells. As shown in Figure 2b , PKR inhibition and interferon-a could not induce IGF-1 expression in CNE1 cells. These results indicate that EBER induces IGF-1 transcription by a mechanism independent of PKR.
Role of IGF-1 in growth of EBV-infected NPC cell lines
A comparison of growth between EBV-positive and -negative CNE1 cells revealed that EBV clearly promoted growth yielding a higher saturation density in CNE1 cells under low (0.1%) serum conditions ( Figure 3a) . Similarly, EBER-trensfected CNE1 cells grew faster and attained a higher saturation density than Neo r -transfected CNE1 cells ( Figure 3b ). To assess the role of IGF-1 in cell growth, EBV-positive CNE1 cells and C666-1 cells were cultured in the presence of an anti-IGF-1 antibody. The anti-IGF-1 antibody inhibited the growth of EBV-positive CNE1 cells and C666-1 cells in a dose-dependent manner (Figure 3c and d) . Furthermore, addition of recombinant IGF-1 to the culture medium of EBV-negative CNE1 cells allowed these cells to grow at a rate similar to EBV-positive CNE1 cells (Figure 3e ). Essentially the same results were also obtained when EBV-negative and -positive HONE1 cells were compared (Figure 1f and g). These results indicated that IGF-1 was an autocrine growth factor for CNE1 and C666-1 cells.
IGF-1 and LMP1 expression in NPC biopsies
To assess the role of IGF-1 in NPC, eight NPC biopsies were examined for IGF-1 expression by RT-PCR assay, and all samples were positive for IGF-1 (Figure 4a) . Although LMP1 was shown to have some pleiotropic biological activities against epithelial cells, the RT-PCR assay of NPC biopsies demonstrated that LMP1 was expressed only in two of eight NPC cases (Figure 4b ).
Transcriptional activation of the IGF-1 gene by EBER
The half-life of IGF-1 mRNA did not differ between EBV-positive and -negative CNE1 cells (Figure 5 ), thus indicating that increased expression of IGF-1 mRNA in EBV-positive CNE1 cells was at the transcriptional level. It was further examined whether EBER activated gene expression from the IGF-1 promoter in CNE1 cells. We constructed a reporter plasmid containing elements À1763 to þ 68 of the human IGF-1 5 0 -flanking region cloned in front of the luciferase gene. The IGF-1 reporter plasmid was transfected into CNE1 cell clones, which carried the EBER plasmid and stably expressed EBER. As shown in Figure 6 , the luciferase activity was significantly higher in EBER-expressing CNE1 cells than in Neo r -transfected CNE1 cells. These results strongly suggest that IGF-1 expression in NPC tissues resulted from transcriptional activation by EBER.
Discussion
The present findings strongly suggest that EBV directly affects the pathogenesis of NPC through a secretion of IGF-1. Since cell lines derived from EBV-positive GC did not exist, we could not examine whether growth of EBV positive carcinoma cells was dependent on EBV in a previous study. EBV-conversion of CNE1 and HONE1 reproduces an in vivo phenotype of EBV infection, namely type I latency, and accompanies IGF-1 expression. On the other hand, EBV-positive C666-1 maintains type I EBV latency, and is positive for IGF-1 expression. Furthermore, NPC tissues consistently express IGF-1. These findings strongly suggest that EBV infection induces IGF-1 expression in NPC tissues.
Interest in IGF-1 and its effect on carcinogenesis has increased recently because high serum concentrations of IGF-1 are associated with increased risks of breast, prostate, colorectal and lung cancers (Yu and Rohan, 2000; Fu¨rstenberger and Senn, 2002) . IGF-1 consists of 70 amino-acid residues (7.65 kDa), and shares 40% homology in amino-acid sequence with proinsulin. IGF-1 is primarily produced by hepatocytes, serving an endocrine function, and is also produced by many other cells, where it may act in an autocrine or paracrine manner. The action of IGF-1 is predominantly mediated through the IGF-1 receptor (IGF-1R). IGF-1R signaling can induce many diverse effects including differentiation, transformation and prevention of apoptosis.
We further demonstrated that EBER was responsible for IGF-1 expression in NPC cells. This is consistent with our previous observation in GC cells (Iwakiri et al., 2003) . Since the half-life of IGF-1 mRNA did not differ between EBV-positive and -negative NPC cells, it was concluded that an increase of IGF-1 mRNA in EBVinfected NPC cells reflected transcriptional activation. EBER is a small RNA, is not transcribed into protein, and is known to bind some cellular proteins such as La, EAP/L22 and PKR . Among them, the association of EBER with PKR has been most intensively studied (Sharp et al., 1993; Yamamoto et al., 2000; Nanbo et al., 2002) . We previously demonstrated that EBER binds PKR, inhibits its phosphorylation, and confers resistance to interferon-induced apoptosis (Nanbo et al., 2002) . On the other hand, the significance of EBER binding with Beside inhibition of PKR activation, we have reported that EBER has various activities, which may be important for oncogenesis (Komano et al., 1999; Kitagawa et al., 2000) . It induces interleukin-10 (IL-10) expression and secreted IL-10 acts as an autocrine growth factor for Burkitt's lymphoma (Kitagawa et al., 2000) . More recently, we demonstrated that EBER induces IGF-1 expression in GC cells and secreted IGF-1 acts as an autocrine growth factor (Iwakiri et al., 2003) . These findings indicate that EBER makes key contributions to both lymphoid and epithelioid carcinogenesis.
The present findings suggest a possible new therapeutic strategy against NPC. Both existing drugs and various newly developed agents acting through the IGF-1 pathways should have great potential as therapeutic or preventive agents for NPC.
Materials and methods
Cell lines and tumor biopsies
CNE1 and HONE are derived from EBV-positive NPC, but are EBV-negative. It is thought that EBV was lost during establishment of the cell lines. Cell line C666-1 is an EBVpositive NPC line (Zeng et al., 1982; Cheung et al., 1999) . CNE1 and HONE cells were cultured in Dulbecco's modified Eagle's medium (Sigma, Saint Louis, MO, USA), and C666-1 cells were cultured in RPMI 1640 medium (Sigma). Both media were supplemented with 10% FBS (Sigma) and antibiotics. An Akata cell clone infected with rEBV, which carries the Neo r gene and the EGFP gene (Maruo et al., 2001) , was cultured in RPMI 1640 medium supplemented with 10% FBS, antibiotics and G418 (700 mg/ml) (sigma). NPC tumor biopsies were obtained from patients diagnosed pathologically.
Establishment of EBV-infected CNE1 and HONE1 cells
CNE1 and HONE1 cells were infected with rEBV (containing the Neo r and EGFP genes described above) using a 'cell-tocell' infection procedure as previously described (Imai et al., 1998) . Briefly, CNE1 and HONE1 cells were cocultured with rEBV-infected Akata cells previously treated with rabbit polyclonal anti-human IgG antibody (Dako, Copenhagen, Denmark) to induce virus production. The culture was then incubated for 3 days at 371C in 5% CO 2 with replacement of half of the medium with fresh medium on day 2. After 3 days cocultivation, the culture was washed four times with phosphate-buffered saline to remove residual Akata cells, and 2 ml of fresh medium was added. On day 5, the cells were reseeded into 24-well plates at 10 4 /ml per well in culture medium containing G418 (500 mg/ml) for selection of rEBVinfected clones.
Immunofluorescence
Expression of EBNA was examined on acetone-methanol (1 : 1)-fixed cells by anticomplement immunofluorescence with reference human serum (titer, Â 640).
Immunoblot analysis
Cells were lysed in lysis buffer (50 mM Tris-HCL (pH 7.5), 150 mM NaCl, 50 mM NaF, 5 mM EDTA, 1% (v/v) Triton X-100, 10% (v/v) glycerol, 1 mM Na 3 VO 4 , 1 mM PMSF, 1 mg/ml pepstatin, 1 mg/ml aprotinin, 1 mg/ml leupeptin). Lysates were resolved by 8% SDS-PAGE and were electrotransferred to nitrocellulose membranes. For protein detection, membranes were probed with anti-LMP1 monoclonal antibody S-12 or human serum followed by anti-mouse or anti-human horseradish peroxidase-conjugated IgG. Membranes were visualized with an ECL Western blotting kit (Amersham Bioscience Corp., Piscataway, NJ, USA).
RT-PCR analysis
Total RNA was isolated from cells or tumor biopsies using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocol. For cDNA synthesis, 100 pmol of a random hexamer (Invitrogen) was added to 1 mg RNA, followed by heating at 941C for 10 min. Then, RNA was reverse transcribed using 200 U of Moloney murine leukemia virus reverse transcriptase (MMLV-RT) (Invitrogen) in reaction buffer containing 50 mM Tris-HCl (pH 8.3), 75 mM KCl, 3 mM MgCl 2 , 10 mM dithiothreitol, 0.5 mM each deoxynucleoside triphosphate, 10 U of RNasin (Promega, Madison, WI, USA) at 371C for 60 min. cDNA aliquots were then subjected to PCR analyses using primer pairs and probes specific for glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and EBV transcripts such as BamHI W, C and Q promoter (Wp, Cp and Qp)-initiated mRNA, LMP2A, LMP2B and BARF0 as previously described (Imai et al., 1998) . Sequences of primer pairs used for detection of growth factor mRNA expression were as follows (described as 5 0 end primer, 3 0 end primer, respectively), IGF-1: 5 0 -TGCTCACCTTCACCAGCTCTGC CA-3 0 , 5 0 -GTGTGGCGCTGGGCAGGGACAGA-3 0 ; EGF:
0 . For DNA amplification, cDNA was denatured at 941C for 2 min (IGF-1, HGF and IL-1b) or 5 min (EGF), primer annealing at 521C for 1 min (IGF-1 and HGF), 631C for 30 s (EGF), 501C for 1 min (IL-1b), and then DNA extension at 721C for 2.5 min (IGF-1 and HGF) or 1 min (EGF and IL-1b) for 30-35 cycles (IGF-1 and HGF) or 35-40 cycles .
Northern blot analysis
In total, 10 mg of total RNA was electrophoresed and transferred to a Nylon membrane. The cDNA probes for EBER or GAPDH were generated by RT-PCR and labeled with alkaline phosphatase using AlkPhos direct labeling kit (Amersham). The membrane was hybridized with probes at 551C, washed under high-stringency conditions, and treated with a chemiluminescent alkaline phosphatase substrate CDPStar (Amersham). were harvested, numbers of cells were counted, and the amounts of IGF-1 in each culture supernatant were corrected as those per the same cell numbers.
Plasmids, transfection and cell cloning
Since the plasmid that contained a single copy of EBER could not induce levels of EBER expression in transfected cells equivalent to those in EBV-infected cells, we used the EBER plasmid that contained 10 tandem repeats of the EBER subfragment (6297-7325 bp) from the EcoRI K fragment of Akata EBV DNA and Neo r gene driven by the simian virus 40 (SV40) promoter (Komano et al., 1999) . The EBNA1 plasmid carries the SV40 promoter-driven Neo r and the EBNA1 gene (Kitagawa et al., 2000) . The BARF0 plasmid carries the SV40 promoter-driven Neo r and the FLAG-tagged BARF0 gene (Kitagawa et al., 2000) . Each of the plasmids was introduced into CNE1 cells by the lipofection method. For transient analysis, cells were harvested 2 days after transfection. For isolation of stable transfectants, transfected cells were selected with complete culture medium containing 500 mg/ml of G418.
Reporter plasmid construction and luciferase assay
The IGF-1 promoter from À1763 to þ 68 was amplified from genomic DNA by PCR. PCR product was digested with MluI and BglII and then subcloned upstream of the luciferase gene of PGV-basic vector 2 (PGV-B2, Wako Pure Chemical Industries, Osaka, Japan). The IGF-1 promoter-luciferase plasmid was transfected into CNE1/EBER cells, which carried the transfected EBER plasmid and stably expressed EBER. All transfections were performed using LIPOFECTAMINE PLUS reagent (Invitrogen) according to the manufacturer's protocol. DNA (1 mg )-lipofectin complexes were added to cells grown in each well of six-well culture plates. After 48 h of transfection, cells were lysed and luciferase activities were determined using Dual-luciferase reporter assay system (Promega). To normalize luciferase activities, activities of PGV reporter plasmid were divided by those of pRL thymidine kinase (TK) control vector that was cotransfected as an internal control. Reproducibility of results was confirmed by three independent transfections and each transfection was carried out in duplicate. Values were expressed as the mean7s.e. of three experiments.
